Note 8, Stock Based Compensation (Details) - USD ($) | 3 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 236,034 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 44.60 | | $ 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share | | | 0 |
Share-based Compensation | $ 6,000,000 | $ 1,000,000 | |
Adient Share Bifurcation | 1 | | |
JCI Share Bifurcation | 10 | | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 1,000,000 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 1 year 6 months | | |
Former Parent Outstanding Remaining Contractual Life | 4 years 7 months | | |
Former Parent Outstanding Aggregate Intrinsic Value | $ 27,000,000 | | |
Adient Outstanding Remaining Contractual Life | 4 years 7 months | | |
Adient Outstanding Aggregate Intrinsic Value | $ 6,000,000 | | |
Former Parent Exercisable Remaining Contractual Life | 4 years 1 month | | |
Former Parent Exercisable Aggregate Intrinsic Value | $ 27,000,000 | | |
Adient Exercisable Remaining Contractual Life | 4 years 7 months | | |
Adient Exercisable Aggregate Intrinsic Value | $ 5,000,000 | | |
Employee Stock Option [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 32.51 | | $ 32.42 |
Weighted Average Price Exercised Prior to 10.31.2016 | $ 27.22 | | |
Weighted Average Options Forfeited prior to 10.31.2016 | 31.71 | | |
Weighted Average Options Converted Prior to 10.31.2016 | 33.28 | | |
Weighted Average Options Converted at Separation | $ 32.49 | | |
Options Forfeited prior to 10.31.2016 | 3,330 | | |
Options Converted Prior to 10.31.2016 | 169,125 | | |
optionsconvertedatseparation | 2,495,543 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options | | | 2,336,028 |
Adient Weighted Average Exercisable | $ 31.95 | | |
Adient Weighted Average Outstanding | $ 33.64 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 2,485,945 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 28.62 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | 4 years 7 months | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 33,000,000 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | 2,861 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) | (6,737) | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ 25.88 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 27.19 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 2,215,004 | | |
Options Exercised Prior to 10.31.2016 | 6,280 | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0 | | |
Former Parent Weighted Average Outstanding | $ 32.40 | | |
formerparentoptionsoutstanding | 2,261,192 | | |
Adientoutstandingoptions | 224,753 | | |
Former Parent Weighted Average Exercisable | $ 28.29 | | |
formerparentoptionsexercisable | 2,014,880 | | |
adientoptionsexercisable | 200,124 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 4 years 1 month | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ 32,000,000 | | |
Restricted Stock [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 45.19 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 2,321,841 | | 1,320,448 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | (1,162,213) | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share | $ 86,000,000 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 45.44 | | $ 46.42 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 50.31 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 280,694 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | (15,152) | | |
Adientoutstandingoptions | 1,269,614 | | |
Weighted Average Options Converted Prior to 10.31.2016 | $ 48.06 | | |
Options Converted Prior to 10.31.2016 | 135,026 | | |
Weighted Average Options Converted at Separation | $ 46.57 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 45.93 | | |
optionsconvertedatseparation | 1,455,474 | | |
Former Parent Weighted Average Remaining Contractual Term | $ 45.59 | | |
formerparentoptionsoutstanding | 1,052,227 | | |
Adient Weighted Average Remaining Contractual Term | $ 45.40 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 2 years 6 months | | |
Stock Appreciation Rights (SARs) [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 670,203 | | 654,694 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 31.37 | | $ 31.26 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $ 670,203 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 29.28 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | (3,354) | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercisable | $ 28.20 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Exercisable | 632,055 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Exercisble Remaining Contractual Term | 4 years | | |
Former Parent Weighted Average Exercisable | $ 27.87 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | 4 years 4 months | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $ 9,000,000 | | |
formerparentoptionsexercisable | 573,533 | | |
Former Parent Exercisable Remaining Contractual Life | 4 years | | |
Former Parent Exercisable Aggregate Intrinsic Value | $ 8,000,000 | | |
Adient Weighted Average Exercisable | $ 31.47 | | |
adientoptionsexercisable | 58,522 | | |
Adient Exercisable Remaining Contractual Life | 4 years | | |
Adient Exercisable Aggregate Intrinsic Value | $ 1,000,000 | | |
Adient Outstanding Remaining Contractual Life | 4 years 4 months | | |
Adient Outstanding Aggregate Intrinsic Value | $ 1,000,000 | | |
Weighted Average Price Exercised Prior to 10.31.2016 | $ 29.68 | | |
Options Exercised Prior to 10.31.2016 | (9,470) | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) | (13,380) | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 46.62 | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 632,055 | | |
Former Parent Outstanding Remaining Contractual Life | 4 years 4 months | | |
Former Parent Outstanding Aggregate Intrinsic Value | $ 8,000,000 | | |
SARS Weighted Average Options Converted Prior to 10.31.2016 | $ 33.16 | | |
SARS Converted Prior to 10.31.2016 | 41,713 | | |
SARS Weighted Average Options Converted at Separation | $ 31.40 | | |
SARSconvertedatseparation | 686,937 | | |
SARS Former Parent Weighted Average Outstanding | $ 31.25 | | |
SARS formerparentoptionsoutstanding | 607,446 | | |
SARS Adient Weighted Average Outstanding | $ 32.53 | | |
SARS Adientoutstandingoptions | 62,757 | | |
Performance Shares [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 44.60 | | |
PSU Weighted Average Price Converted 10.31.2016 | $ 0 | | |
PSU converted 10.31.2016 | 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | $ 236,034 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 0 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 0 | | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 18,000,000 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 2 years 11 months | | |